Category: News

Ilona Jaspers, PhD, director of the UNC Center for Environmental Medicine, Asthma, and Lung Biology, co-authored a study with colleagues from the UNC Gillings School of Global Public Health and the U.S. Environmental Protection Agency on possible effects of wildfire smoke in-utero or in the first weeks of life. Read...

A new study by researchers in the UNC School of Medicine, including Meghan Rebuli, PhD, Ilona Jaspers, PhD, and Kevin T. Cao, has found that SARS-CoV-2 mRNA vaccination produces a robust immune response in the nasal cavity. Read the full story here.

WRAL News interviewed David Peden, MD, concerning the lung health effects of wildfire smoke from Canada, as well as what people can do to mitigate the effects of the smoke. The interview, “‘There are more opportunities for fires to get started’: UNC doctor on health effects of wildfires and what...

In a Triangle Business Journal article, David B. Peden, MD, discusses how UNC’s new Clinical Research Alliance (CRA) can be used to develop multi-site clinical trials. The article, “New UNC group wants to land larger clinical studies,” can be read here.

David B. Peden, MD, was interviewed in a NEWSTALK Tonight radio broadcast on the topic of wildfire pollution. NEWSTALK Tonight is a feature on the NEWSTALK 1010 Internet radio channel out of Toronto, Canada. You can listen to a recording of the broadcast with Dr. Peden here.

The UNC School of Medicine has launched its Clinical Research Alliance (CRA), an organization within the school that will streamline all aspects of its clinical research enterprise, including ground-up support for scientists conducting multi-site trials, industry partners interested in collaboration leading toward new treatments and discoveries, as well as people...

David Peden, MD, was consulted for a Raleigh News & Observer article on precautions that can be taken during air quality warnings. The article, “With air quality warnings in NC, what should I do or not do to stay safe? Experts answer,” can be found here.

Researchers at the UNC School of Medicine’s International Center for the Advancement of Translational Science, Department of Microbiology and Immunology, and Institute for Global Health and Infectious Diseases have demonstrated the important role of human T cells in controlling RSV infection in the absence of an antibody response. Led by J....

Jennifer Goralski, MD, has been consulted for several news articles reporting the FDA’s expansion of age limits for Trikafta to treat younger children with cystic fibrosis. Dr. Goralski was a lead principal investigator in the clinical trial on which the FDA based its decision. The articles can be found at...

The Institute for Global Health & Infectious Diseases (IGHID) has a new hub of collaborative work focused on combating antimicrobial resistance (AMR). Leveraging the Institute’s pan-university framework, the program brings together expertise in basic science, pharmacology, epidemiology, clinical research, and environmental studies from schools and departments all across UNC. Among...